http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100382042-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2000-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100382042-B1 |
| titleOfInvention | Pharmaceutical compositions containing βig-h3 recombinant protein or its domains for wound healing |
| abstract | The present invention relates to a pharmaceutical composition comprising a βig-h3 protein or a partial domain thereof for the treatment of wounds, and more particularly, to a βig-h3 recombinant protein, ie, natural βig-h3, which has been recombinantly genetically modified. Recombinant protein containing all four fas-1 domains or recombinant protein containing one or more of the second or fourth of four domains is based on water-soluble chitosan, a natural high molecular material effective for henching or wound healing. It relates to a pharmaceutical composition mixed as a base. The pharmaceutical composition of the present invention shows an excellent effect on the treatment of wounds by the action of re-epithelialization and collagen fiber formation by the βig-h3 protein, an active ingredient thereof, in particular the chitosan mixed pharmaceutical composition is antimicrobial, The wound healing effect due to the biocompatibility and the absorption of exudate can not only reduce the number of wound treatments but also can be useful for the treatment of chronic wounds. |
| priorityDate | 2000-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 306.